Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2017 Aug 16;1(8):780–791. doi: 10.1002/hep4.1080

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2017 The Authors. Hepatology Communications published by Wiley Periodicals, Inc., on behalf of the American Association for the Study of Liver Diseases.

This is an open access article under the terms of the Creative Commons Attribution‐NonCommercial‐NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.

PMC Copyright notice

Comparison of Mac‐2bp and WFA⁺‐M2BP as liver fibrosis prediction biomarkers. (A) Correlation between serum Mac‐2bp levels and liver fibrosis stage (upper panel). Correlation between serum WFA⁺‐M2BP levels and liver fibrosis stage (middle panel). The table presents the results for the mean values of Mac‐2bp and WFA⁺‐M2BP at each liver fibrosis stage. (B) ROC curves of Mac‐2bp and WFA⁺‐M2BP for the prediction of advanced liver fibrosis (≥F2) in patients with biopsy‐proven NAFLD. The table presents the results for the efficacy of each biomarker. NPV, negative predictive value; N.S., not significant; PPV, positive predictive value; Sen, sensitivity; Spe, specificity.